Oregon Health & Science University researchers unlocked HIV vaccine candidate’s mysteries 20 years later
On Mar. 25, 2021, about two decades after first devising a new kind of vaccine, Oregon Health &…
City of Hope researchers developing COVID-19 vaccine
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
UI Microbiology Professor Mark Stinski made the discoveries of CMV promoter and was named Iowa Inventor of the Year
On Sept. 30, 2003, University of Iowa (UI) Microbiology Professor Mark Stinski made the discoveries of CMV promoter…
Pacific Northwest team unveiled the largest virus proteome to date
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
Biotechnology | FDA | HIV | Life Science News | Therapeutics
Genentech drug Valcyte (valganciclovir hydrochloride) was approved
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
McGill University researcher Dr. Kelvin Ogilvie developed Ganciclovir to treat or prevent cytomegalovirus infections
In 1980, McGill University researcher Dr. Kelvin Kenneth Ogilvie developed Ganciclovir to treat or prevent cytomegalovirus (CMV) infections….